- Nachrichtendetail
-
22.02.2024 22:06:01 - dpa-AFX: *BIOMARIN Q4 REVENUES $646.2 MLN VS. $537.5 MLN LAST YEAR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BioMarin Pharmaceutical | 924801 | NASDAQ | 80,820 | 06.06.24 21:04:38 | +1,150 | +1,44% | 80,800 | 80,830 | 79,020 | 79,670 |
